Cytomedix, Inc. (CMXI)
-OTC BB 0.50 0.00(0.00%) May 17, 12:03PM EDT
| Prev Close: | 0.50 |
|---|
| Open: | 0.49 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 1.50 |
|---|
| Beta: | -1.04 |
|---|
| Next Earnings Date: | 12-Aug-13 |
|---|
| Day's Range: | 0.46 - 0.50 |
|---|
| 52wk Range: | 0.43 - 2.32 |
|---|
| Volume: | 35,500 |
|---|
| Avg Vol (3m): | 205,524 |
|---|
| Market Cap: | 52.17M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.23 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- CYTOMEDIX INC FinancialsEDGAR Online Financials(Fri, May 17)
- Cytomedix to Present at the World Stem Cells & Regenerative Medicine Congress 2013Marketwired(Fri, May 17)
- Does Cell Therapy Hold The Key To Treating Stroke?at Seeking Alpha(Mon, May 13)
- Cytomedix's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Fri, May 10)
- Cytomedix Reports First Quarter 2013 Financial ResultsMarketwired(Thu, May 9)
- CYTOMEDIX INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu, May 9)
- Cytomedix to Host First Quarter 2013 Financial Results Conference Call on Friday, May 10, 2013Marketwired(Mon, May 6)
- Cytomedix AutoloGel(TM) Registry to Be Featured at the Symposium on Advanced Wound Care (SAWC-SPRING) on May 5, 2013Marketwired(Thu, May 2)
- Cytomedix to Present at the 12th Annual Needham Healthcare ConferenceMarketwired(Fri, Apr 26)
- Cytomedix, Inc. to Present at Regen Med Investor Day 2013Marketwired(Wed, Apr 10)
- Advanced Cell Technology, Cytomedix and Mesoblast to Provide Corporate and Clinical Updates at Regen Med Investor DayPR Newswire(Tue, Apr 9)
- Cytomedix Announces Appointment of Steven A. Shallcross as Chief Financial OfficerMarketwired(Wed, Apr 3)
- CYTOMEDIX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal OfficeEDGAR Online(Wed, Apr 3)
- Cytomedix's CEO Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha(Tue, Mar 19)
- Cytomedix Reports 2012 Fourth Quarter and Full Year Financial ResultsMarketwired(Mon, Mar 18)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 5.29 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | 3.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Cytomedix, Inc. develops, sells, and licenses regenerative biological therapies to primarily address the areas of wound care, infection control, and orthopedic surgery.
View More